Kindred Biosciences
KIN
#7796
Rank
NZ$0.76 B
Marketcap
NZ$16.80
Share price
0.11%
Change (1 day)
N/A
Change (1 year)

Earnings for Kindred Biosciences (KIN)

Earnings in 2021 (TTM): -NZ$57.26 Million

According to Kindred Biosciences 's latest financial reports the company's current earnings are NZ$7.92 Million. In 2020 the company made an earning of -NZ$32.12 Million, an increase over its 2019 earnings that were of -NZ$0.12 Billion.

Earnings history for Kindred Biosciences from 2013 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-NZ$57.26 Million78.29%
2020-NZ$32.12 Million-71.74%
2019-NZ$0.12 Billion22.07%
2018-NZ$93.11 Million61.93%
2017-NZ$57.5 Million42.78%
2016-NZ$40.27 Million-18.68%
2015-NZ$49.52 Million0.12%
2014-NZ$49.46 Million359.03%
2013-NZ$10.78 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
NZ$63.15 B-87,677.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Zoetis
ZTS
NZ$5.65 B-7,943.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.21 B-17,034.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Phibro Animal Health
PAHC
NZ$0.33 B-562.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Heska Corporation
HSKA
-NZ$33.31 Million-53.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Petco
WOOF
NZ$0.23 B-425.21%๐Ÿ‡บ๐Ÿ‡ธ USA